ABT Stock: Abbott Laboratories Stock Price, Analysis & Insights
Get live abt stock price $124.66, comprehensive Abbott Laboratories stock analysis, charts, news, and expert forecast. Real-time abt stock data and investment insights.
Loading chart...
Company Overview
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Company Information
- CEO
- Robert Ford
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 114000
Contact Information
- Website
- https://www.abbott.com
- Address
- 100 Abbott Park Road
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Market leader with 217.0 billion market capitalization
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 15.7)
✓ Lower volatility stock (Beta: 0.72) may provide portfolio stability
Business Model & Strategy
Abbott Laboratories operates in the Medical - Devices industry, focusing on medical services, pharmaceutical development, and healthcare delivery. As a large-cap company, Abbott Laboratories benefits from scale advantages, market presence, and established operations. Under the leadership of CEO Robert Ford, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Medical - Devices model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
Abbott Laboratories competes in the Medical - Devices within the broader Healthcare. With 217.0 billion in market capitalization, the company is positioned as a market leader in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the New York Stock Exchange, Abbott Laboratories provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating Abbott Laboratories should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Abbott Laboratories shareholders
- ⚠Market volatility can significantly impact stock price, especially for large-cap equities
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Abbott Laboratories
- ⚠Investors should consider how Abbott Laboratories fits within their overall portfolio allocation
Market Cap
216.97B
P/E Ratio
15.66
Beta
0.72
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 216.97B market capitalization
- Trading Volume: 2.22M shares traded today
- Price Range: 52-week range of $110.86 - $141.23
- Exchange: Listed on New York Stock Exchange
Financial Metrics
Market Analysis for Abbott Laboratories
Abbott Laboratories (ABT) operates in the Medical - Devices industry within the Healthcare sector. With a current market capitalization of 216.97B, the company represents a significant player in its market. The stock is currently trading at $124.66 with a negativedaily change of 0.51%.
The company's 114000 employee base and presence on the New York Stock Exchangeexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of 15.66, beta of 0.72, and 52-week price range from $110.86 to $141.23when evaluating investment opportunities.
Why Invest in Abbott Laboratories?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (New York Stock Exchange)
- • Experienced leadership under Robert Ford
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.